These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8030103)

  • 1. Influence of cytomegalovirus antibody status on graft survival in renal transplantation.
    Fauchald P; Leivestad T; Rollag H; Albrechtsen D; Sødal G
    Transplant Proc; 1994 Jun; 26(3):1725. PubMed ID: 8030103
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of cytomegalovirus infection in kidney recipients.
    Bilgin N; Karakayali H; Moray G; Akkoç H; Turan M
    Transplant Proc; 1996 Aug; 28(4):2314-5. PubMed ID: 8769233
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors influencing cadaver kidney graft survival in two cyclosporine periods.
    Pappalettera M; Pizzi C; Cardillo M; Piccolo G; Aniasi A; Lecchi L; Poli F; Sirchia G
    Transplant Proc; 1994 Oct; 26(5):2533-4. PubMed ID: 7940779
    [No Abstract]   [Full Text] [Related]  

  • 4. Vascular rejection of renal allografts is linked to CMV IgG, positive organ donor.
    Tenschert W; Dittmer R; Harfmann P; Cremaschi L; Meyer-Moldenhauer WH; Arndt R; Klosterhalfen H
    Transplant Proc; 1991 Oct; 23(5):2641-2. PubMed ID: 1656565
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of HLA mismatching on the incidence of cytomegalovirus infection in living-related renal transplantations.
    Haberal M; Demirağ A; Turan M; Bilgin N; Büyükpamukçu N; Arslan G
    Transplant Proc; 1995 Oct; 27(5):2687-90. PubMed ID: 7482876
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytomegalovirus infection and kidney graft survival.
    Spencer ES; Fjeldborg O; Andersen HK
    Scand J Urol Nephrol Suppl; 1981; 64():128-31. PubMed ID: 6293049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of prospective matching for cytomegalovirus status in renal transplant recipients.
    Ludwin D; White N; Tsai S; Chernesky M; Achong M; Smith EK
    Transplant Proc; 1987 Aug; 19(4):3433-4. PubMed ID: 3039700
    [No Abstract]   [Full Text] [Related]  

  • 8. Positive donor/recipient CMV status is not a detrimental factor for renal allograft/patient survival.
    Krishnan G; Vaughn WK; Capelli JP; Glass NR
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1485-6. PubMed ID: 8382877
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of renal transplants obtained from anti-HCV positive donors.
    Gómez E; Aguado S; Gago E; Martinez A; Cimadevilla R; Melón S; de Oña M; Alvarez-Grande J
    Transplant Proc; 1991 Oct; 23(5):2654-5. PubMed ID: 1656567
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytomegalovirus infection in kidney transplantation: prophylaxis and management.
    Bulinski P; Toledo-Pereyra LH; Dalal S; Hernandez G
    Transplant Proc; 1996 Dec; 28(6):3310-1. PubMed ID: 8962286
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship of epidemiology and treatment factors to infection and allograft survival in renal transplantation.
    Betts RF
    Birth Defects Orig Artic Ser; 1984; 20(1):87-99. PubMed ID: 6329375
    [No Abstract]   [Full Text] [Related]  

  • 12. Kidney transplantation, the Halifax experience.
    Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
    Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of HLA matching on kidney allograft survival.
    Suciu-Foca N; Cohen DJ; Benvenisty AI; Benstein JA; Reed EF; Ho E; Hardy MA
    Transplant Proc; 1996 Feb; 28(1):121-2. PubMed ID: 8644140
    [No Abstract]   [Full Text] [Related]  

  • 14. The incidence of cytomegalovirus infection in kidney recipients.
    Cuhadaroğlu S; Tokyay R; Velidedeoğlu E; Haberal M
    Transplant Proc; 1992 Oct; 24(5):1924-5. PubMed ID: 1329288
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of presence of HBs antigen and anti-hepatitis C virus and anti-cytomegalovirus antibodies on transplanted kidney survival.
    Sieńko J; Wiśniewska M; Ciechanowski K; Rózański J; Domański L; Myslak M; Kamiński M; Sulikowski T; Pabisiak K; Romanowski M; Mizerski A; Tejchman K; Nowacki M; Ostrowski M; Bohatyrewicz R
    Transplant Proc; 2006; 38(1):136-8. PubMed ID: 16504685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological status of cytomegalovirus and outcome of renal transplantation.
    Niaudet P; Raguin G; Lefevre JJ; Busson M; Cabau N; Fortier B; Boue A; Broyer M; Bedrossian J; Fries D; Kreis H; Sraer JD
    Kidney Int Suppl; 1983 May; (14):S-50-3. PubMed ID: 6308330
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of donor age on graft function and graft survival in cadaver renal transplantation.
    Kumar MS; Stephan R; Chui J; Chvala RP; Olshan A; Krevolin L; Abouna GM
    Transplant Proc; 1993 Jun; 25(3):2183-4. PubMed ID: 8516862
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of sequence-specific oligotyping in determining HLA-DR compatibility in cadaver kidney transplantation. The North Italy Transplant Program Working Group on Improvement of Kidney Transplantation.
    Poli F; Scalamogna M; Pappalettera M; Mascaretti L; Angela AN; Sirchia G
    Transplant Proc; 1993 Feb; 25(1 Pt 1):203-5. PubMed ID: 8438271
    [No Abstract]   [Full Text] [Related]  

  • 19. Does the donor age influence graft survival in renal transplantation?
    Sakellariou G; Daniilidis M; Alexopoulos E; Karagiannis A; Papadimitriou M
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2071-3. PubMed ID: 3274472
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival of serologically HLA typed and matched cadaveric kidney transplants and patients: influence of serologic retyping of donors.
    Thorogood J; Doxiadis II; Schreuder GM; Persijn GG; van Rood JJ
    Transplant Proc; 1993 Dec; 25(6):3051-2. PubMed ID: 8266449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.